142 related articles for article (PubMed ID: 9188107)
1. Unapproved uses of approved drugs.
Coté CJ
Paediatr Anaesth; 1997; 7(2):91-2. PubMed ID: 9188107
[No Abstract] [Full Text] [Related]
2. Unapproved uses of approved drugs: the physician, the package insert, and the Food and Drug Administration: subject review. American Academy of Pediatrics Committee on Drugs.
Pediatrics; 1996 Jul; 98(1):143-5. PubMed ID: 8668390
[TBL] [Abstract][Full Text] [Related]
3. Off-label use of approved drugs.
Landow L
Chest; 1999 Sep; 116(3):589-91. PubMed ID: 10492256
[No Abstract] [Full Text] [Related]
4. Psychotropic and neurotropic agents in dermatology: unapproved uses, dosages, or indications.
Koo JY; Ng TC
Clin Dermatol; 2002; 20(5):582-94. PubMed ID: 12435529
[No Abstract] [Full Text] [Related]
5. Psychiatric promise: old drugs, new uses.
Wick JY
Am Pharm; 1993 Feb; NS33(2):47-56. PubMed ID: 8456746
[No Abstract] [Full Text] [Related]
6. Stoning a dead bird: advertising limits on approved new drugs.
Strobos J
Food Drug Law J; 1995; 50(4):533-51. PubMed ID: 10343018
[No Abstract] [Full Text] [Related]
7. Unapproved prescription cough, cold, and allergy drug products: recent US Food and Drug Administration regulatory action on unapproved cough, cold, and allergy medications.
Ostroff C; Lee CE; McMeekin J
Chest; 2011 Aug; 140(2):295-300. PubMed ID: 21813527
[TBL] [Abstract][Full Text] [Related]
8. Antihelmintic and antiparasitic drugs: unapproved uses or indications.
Goihman-Yahr M
Clin Dermatol; 2000; 18(1):113-7. PubMed ID: 10701092
[No Abstract] [Full Text] [Related]
9. FDA targets unapproved drugs.
Young D
Am J Health Syst Pharm; 2007 Feb; 64(4):347-8. PubMed ID: 17299170
[No Abstract] [Full Text] [Related]
10. Off-label or out of bounds? Prescriber and marketer liability for unapproved uses of FDA-approved drugs.
O'Reilly J; Dalal A
Ann Health Law; 2003; 12(2):295-324, table of contents. PubMed ID: 12856461
[TBL] [Abstract][Full Text] [Related]
11. Off-label use of prescription drugs.
Hill M
Dermatol Nurs; 2000 Aug; 12(4):238, 256. PubMed ID: 11912659
[No Abstract] [Full Text] [Related]
12. Immunosuppressant and cytotoxic drugs: unapproved uses or indications.
Abel EA
Clin Dermatol; 2000; 18(1):95-101. PubMed ID: 10701090
[No Abstract] [Full Text] [Related]
13. Antimalarials: unapproved uses or indications.
Wolf R; Wolf D; Ruocco V
Clin Dermatol; 2000; 18(1):17-35. PubMed ID: 10701084
[No Abstract] [Full Text] [Related]
14. Dapsone: unapproved uses or indications.
Wolf R; Tüzün B; Tüzün Y
Clin Dermatol; 2000; 18(1):37-53. PubMed ID: 10701085
[No Abstract] [Full Text] [Related]
15. Antibiotics: unapproved uses or indications.
Sadick NS
Clin Dermatol; 2000; 18(1):11-6. PubMed ID: 10701083
[No Abstract] [Full Text] [Related]
16. FDA reform in Congress: AIDS community absent. Food and Drug Administration.
James JS
AIDS Treat News; 1995 Apr; (no 220):4-5. PubMed ID: 11362320
[TBL] [Abstract][Full Text] [Related]
17. Evaluating the off-label use of medications in children.
Eiland LS; Knight P
Am J Health Syst Pharm; 2006 Jun; 63(11):1062-5. PubMed ID: 16709893
[No Abstract] [Full Text] [Related]
18. Antiviral drugs: unapproved uses, dosages, or indications.
Rebora A
Clin Dermatol; 2002; 20(5):474-80. PubMed ID: 12435517
[No Abstract] [Full Text] [Related]
19. Off-label uses of drugs in children.
Blumer JL
Pediatrics; 1999 Sep; 104(3 Pt 2):598-602. PubMed ID: 10469797
[No Abstract] [Full Text] [Related]
20. Off-label drug use.
Dooley AG
Med Health R I; 2007 Feb; 90(2):63-5. PubMed ID: 17500258
[No Abstract] [Full Text] [Related]
[Next] [New Search]
